The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb; Merck
Treatment outcomes of cutaneous adverse events to immune checkpoint inhibitors.
 
Jennifer Wu
No Relationships to Disclose
 
Azael Freites-Martinez
No Relationships to Disclose
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - AstraZeneca; Bristol-Myers Squibb; Medscape; Peerview; UpToDate; Vindico
Consulting or Advisory Role - Agensys; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; EMD Serono; Inovio Pharmaceuticals; Lilly; Merck; Roche/Genentech; Sanofi; Seagen
Research Funding - Agensys (Inst); Genentech (Inst); Genentech/Roche (Inst); Incyte; Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Paul B. Chapman
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Takeda
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Naiyer A. Rizvi
Leadership - ARMO BioSciences
Stock and Other Ownership Interests - ARMO BioSciences; Gritstone Bio
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Regeneron
 
Larisa J. Geskin
No Relationships to Disclose
 
Vanessa A. Reed
No Relationships to Disclose
 
Stephen W Dusza
No Relationships to Disclose
 
Alina Markova
No Relationships to Disclose
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Celgene (I); Kleo Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca; Merck; Moderna Therapeutics
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Clinical Care Options; Potomac Center for Medical Education
 
Donald Chan
No Relationships to Disclose
 
Adriana Lopez
No Relationships to Disclose
 
Chih-Hsun Yang
No Relationships to Disclose
 
Wen-Hung Chung
No Relationships to Disclose
 
Mario E. Lacouture
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Boehringer Ingelheim; Foamix; Janssen Research & Development; Legacy Healthcare Services; Novartis; Novocure; Quintiles
Research Funding - Berg Pharma (Inst); Bristol-Myers Squibb